Resource Summary

Clinical Question:
Which elderly patients should be offered what type of statin for cardiovascular disease (CVD) prevention?

Bottom-Line:
For primary prevention age 65-75^ consider moderate- potency statins (example 10-20mg atorvastatin) for moderate or higher risk individuals (≥10 percent risk of CVD over 10 years based on Framingham score). No evidence to start statins in primary prevention patients >75. In secondary prevention age 65-82^ there is evidence for moderate-potency (to high^ as tolerated) statin. Pravastatin should likely not be first-line given the possible cancer signal for those >65.


*** Original Documents can be found and downloaded using the link provided below ***

https://www.acfp.ca/tools-for-practice/

Publication Date: 2015-1-5
Last Updated on PCR: 2017-03-31 16:41:42